tirzepatide surpass 4 surpass-4 versus insulin glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo Post Hoc Analysis of SURPASS-1

Fat transfer uses your own fat for full-face rejuvenation and longer-lasting results

Effect of verapamil on allyl alcohol hepatotoxicity

Systemic Cytokine Expression in Diabetes Is Associated with Prolonged Gastrointestinal Transit Times and Cardinal Gastroparesis Symptoms

Innovent Biologics is moving fast with mazdutide, a dual GLP1/glucagon agonist already approved in China, giving it a firstmover advantage in the worlds fastestgrowing obesity market and creating regional pressure on Novo and Lillys global dominance

For white blood cells (WBCs), blood samples were collected from rats 1 h before and after glucose gavage (2 g/kg body weight)